March 18, 2014 – Apta Biosciences with offices in the U.K. and Singapore is a spinoff of a decade of research at Fujitsu Laboratories. The company recently raised about $2.7 million U.S., 106% of its financial target through the Syndicate Room, a biotech equity crowdfunding site. Apta is the developer of a line of adaptamers … Continue reading Biomedicine Update: Artificial Antibody Company Exceeds Crowdfunding Goal